Safety and Effectiveness of Tramadex-OD After Knee Arthroscopy
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Extended-release tramadol is indicated for the management of moderate to severe pain in
adults who require around-the-clock treatment. It provides an extended duration of action,
more constant plasma concentrations, a reduced dosing frequency, and the potential for
improved compliance and therapeutic outcomes.
The present study was designed to evaluate the safety and effectiveness of this medication in
the treatment of early postoperative pain after knee arthroscopy.